Producing induced pluripotent stem cells (iPSCs) from human tissue for use in personalized medicine strategies or therapeutic testing is at the forefront of medicine. Therefore, identifying a source of cells to reprogram that is easily accessible via a simple noninvasive procedure is of great clinical importance. Reprogramming these cells to iPSCs through nonintegrating methods for genetic manipulation is paramount for regenerative purposes. Here, we demonstrate reprogramming of oral mucosal lamina propria progenitor cells from patients undergoing routine dental treatment. Reprogramming was performed utilizing nonintegrating plasmids containing all 6 pluripotency genes (OCT4, SOX2, KLF4, NANOG, LIN28, and cMYC). Resulting iPSCs lacked genetic integration of the vector genes and had the ability to differentiate down mesoderm, ectoderm, and endoderm lineages, demonstrating pluripotency. In conclusion, oral mucosal lamina propria progenitor cells represent a source of cells that can be obtained with minimal invasion, as they can be taken concurrently with routine treatments. The resulting integration-free iPSCs therefore have great potential for use in personalized medicine strategies.
AasenTRayaABarreroMJGarretaEConsiglioAGonzalezFVassenaRBilicJPekarikVTiscorniaG. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 26(11):1276–1284.
2.
BhattacharyaBCaiJLuoYMiuraTMejidoJBrimbleSNZengXSchulzTCRaoMSPuriRK. 2005. Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol. 5:22.
3.
ChenGGulbransonDRHouZBolinJMRuottiVProbascoMDSmuga-OttoKHowdenSEDiolNRPropsonNE. 2011. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 8(5):424–429.
DaviesLCLockeMWebbRDRobertsJTLangleyMThomasDWArcherCWStephensP. 2010. A multipotent neural crest-derived progenitor cell population is resident within the oral mucosa lamina propria. Stem Cells Dev. 19(6):819–830.
6.
DaviesLCLonniesHLockeMSundbergBRosendahlKGotherstromCLe BlancKStephensP. 2012. Oral mucosal progenitor cells are potently immunosuppressive in a dose-independent manner. Stem Cells Dev. 21(9):1478–1487.
7.
EgusaHOkitaKKayashimaHYuGFukuyasuSSaekiMMatsumotoTYamanakaSYataniH. 2010. Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One. 5(9):e12743.
8.
FusakiNBanHNishiyamaASaekiKHasegawaM. 2009. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 85(8):348–362.
9.
GurdonJBElsdaleTRFischbergM. 1958. Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature. 182:64–65.
10.
LiWZhouHAbujarourRZhuSYoung JooJLinTHaoEScholerHRHayekADingS. 2009. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells. 27(12):2992–3000.
11.
LinTAmbasudhanRYuanXLiWHilcoveSAbujarourRLinXHahmHSHaoEHayekA. 2009. A chemical platform for improved induction of human iPSCs. Nat Methods. 6(11):805–808.
12.
LivakKJSchmittgenTD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25(4):402–408.
13.
LuHETsaiMSYangYCYuanCCWangTHLinXZTsengCPHwangSM. 2011. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system. Exp Cell Res. 317(13):1895–1903.
14.
LowryWERichterLYachechkoRPyleADTchieuJSridharanRClarkATPlathK. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 105(8):2883–2888.
15.
MaheraliNAhfeldtTRigamontiAUtikalJCowanCHochedlingerK. 2008. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell. 3(3):340–345.
16.
MaheraliNSridharanRXieWUtikalJEminliSArnoldKStadtfeldMYachechkoRTchieuJJaenischR. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 1(1):55–70.
17.
MaliPYeZHommondHHYuXLinJChenGZouJChengL. 2008. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells. 26(8):1998–2005.
18.
MerlingRKSweeneyCLChoiUDe RavinSSMyersTGOtaizo-CarrasqueroFPanJLintonGChenLKoontzS. 2013. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood. 121(14):e98–e107.
19.
MiyoshiKTsujiDKudohKSatomuraKMutoTItohKNomaT. 2010. Generation of human induced pluripotent stem cells from oral mucosa. J Biosci Bioeng. 110(3):345–350.
20.
NakagawaMKoyanagiMTanabeKTakahashiKIchisakaTAoiTOkitaKMochidukiYTakizawaNYamanakaS. 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 26(1):101–106.
SomersAJeanJCSommerCAOmariAFordCCMillsJAYingLSommerAGJeanJMSmithBW. 2010. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 28(10):1728–1740.
StephensPDaviesKJal-KhateebTShepherdJPThomasDW. 1996. A comparison of the ability of intra-oral and extra-oral fibroblasts to stimulate extracellular matrix reorganization in a model of wound contraction. J Dent Res. 75(6):1358–1364.
25.
TakahashiKTanabeKOhnukiMNaritaMIchisakaTTomodaKYamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131(5):861–872.
26.
TakahashiKYamanakaS. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126(4):663–676.
27.
Takeda-KawaguchiTSugiyamaKChikusaSIidaKAokiHTamaokiNHatakeyamaDKunisadaTShibataTFusakiN. 2014. Derivation of iPSCs after culture of human dental pulp cells under defined conditions. PLoS One. 9(12):e115392.
28.
TangCLeeASVolkmerJPSahooDNagDMosleyARInlayMAArdehaliRChavezSLPeraRR. 2011. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol. 29(9):829–834.
29.
ThomsonJAItskovitz-EldorJShapiroSSWaknitzMASwiergielJJMarshallVSJonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 282(5391):1145–1147.
30.
WadaNWangBLinNHLaslettALGronthosSBartoldPM. 2011. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J Periodontal Res. 46(4):438–447.
31.
WarrenLManosPDAhfeldtTLohYHLiHLauFEbinaWMandalPKSmithZDMeissnerA. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 7(5):618–630.
YamanakaS. 2007. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 1(1):39–49.
34.
YanXQinHQuCTuanRSShiSHuangGT. 2010. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev. 19(4):469–480.
35.
YuJHuKSmuga-OttoKTianSStewartRSlukvinIIThomsonJA. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 324(5928):797–801.
36.
YuJVodyanikMASmuga-OttoKAntosiewicz-BourgetJFraneJLTianSNieJJonsdottirGARuottiVStewartR. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318(5858):1917–1920.
37.
ZouXYYangHYYuZTanXBYanXHuangGT. 2012. Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation. Stem Cell Res Ther. 3(5):43.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
